Welcome!
Tianjin Zhong Xin Pharmaceutical Group Corporation
Results
Tianjin Zhong Xin Pharma posts 6% rise in FY20 earnings to $135.8 mil
For the FY2020, the group has proposed a dividend of RMB232.1 million or RMB3.0 for every 10 shares in the capital of the group.
March 30, 2021
Results
Tianjin Zhong Xin's 3Q earnings fall 11% to $16.8 mil
SINGAPORE (Oct 30): Tianjin Zhong Xin Pharmaceutical Group Corporation posts an 11% decline in earnings to RMB 82.0 million ($16.8 million) for the 3Q ended September, from RMB 91.6 million a year ago.
October 30, 2017